Website intended for a NZ health professional readership
We are on our summer break and the editorial office is closed until 18 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists have selected articles from our 2020 news and clinical archives, The Conversation and other publications with which we share content. Please note the comment function has been turned off while we are away. Happy reading.
From Martin Johnston: I chose this article because it's a good example of how there was no established playbook for the pandemic and the difficulties that created as the guidelines were knocked into shape
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
